Airsculpt Technologies, Inc. (AIRS)

Sector - Healthcare

IPO Profile

About company

They are an experienced, fast-growing national provider of body contouring procedures delivering a premium consumer experience. At Elite Body Sculpture, they provide custom body contouring using their proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. It is their mission to generate the best results for their patients. They believe their treatment results and elite patient experience have positioned Elite Body Sculpture as a preferred body contouring brand. They performed over 5,800 body contouring procedures in 2020. Their proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches and no general anesthesia to achieve transformational change that appears both natural and smooth. Their patients are guided by surgeons and patient care consultants through every step of the experience. Their patients are awake and can converse with their surgeon or listen to music during their procedure and often resume normal activity the next day. They deliver their body contouring procedures through a growing, nationwide footprint of 16 centers across 13 states as of October 5, 2021. Their centers, located in metropolitan and suburban areas, offer a premium patient experience and luxurious, spa-like atmosphere.
Industry
Services-general Medical & Surgical Hospitals, Nec
CEO CFO
-
Employees Founded
230 2012

Contacts

Address: 400 Alton Road, Unit Th-103m, Miami Beach, Florida 33139, Uss

Telephone: (786) 709-9690

Web page: http://www.elitebodysculpture.com

IPO information

First Trade Date 10/29/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range $15.00-$17.00
Share prices ($)
11.00
12.00
11
0
0
Price Low Price High Priced Open 1st day Close 1st day

Shares & Volumes

Shares Initial (MM) 10
Shares Revised (MM) 7
Expected offer amount (MM) $160
Realized offer amount(MM) $77

Financial Data (last reporting year)

Market Cap (MM) $639.86
Revenues (MM) $101.5
Net Income (Loss) (MM) $7.8

Voting

What do you think will happen with the GLSI share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes:
The lead left underwriter: Morgan Stanley

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Morgan Stanley/ Piper Sandler/ SVB Leerink
CO-Managers
First Liberties Financial/ Raymond James

Sector: Healthcare

Tweets about $AIRS